Qumas

Qumas is a leading provider of enterprise compliance and quality management solutions specifically designed for the life sciences industry. The company offers a comprehensive software platform that enables pharmaceutical, biotechnology, and medical device organizations to manage regulatory content and quality processes in a centralized environment. Its solutions facilitate document management, CAPA (Corrective and Preventive Actions), and regulatory submissions, ensuring strict adherence to global standards such as FDA 21 CFR Part 11. By streamlining the transition from research and development to commercial manufacturing, Qumas helps companies mitigate risk and accelerate time-to-market. Following its acquisition by Accelrys and subsequent integration into Dassault Systèmes' BIOVIA brand, the Qumas technology continues to serve as a critical component of digital transformation in scientific industries.